A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction.
A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction.
复制标题
一种新型可控硫化氢释放分子可保护人类皮肤角质形成细胞免受甲基乙二醛引起的损伤和功能障碍。
DOI:
10.1159/000366339
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Zhang MF
中科院分区:
文献类型:
--
作者:
Yang CT;Zhao Y;Xian M;Li JH;Dong Q;Bai HB;Xu JD;Zhang MF
Delayed wound healing is a common skin complication of diabetes, which is associated with keratinocyte injury and dysfunction. Levels of methylglyoxal (MGO), an α-dicarbonyl compound, are elevated in diabetic skin tissue and plasma, while levels of hydrogen sulfide (H2S), a critical gaseous signaling molecule, are reduced. Interestingly, the gas has shown dermal protection in our previous study. To date, there is no evidence demonstrating whether MGO affects keratinocyte viability and function or H2S donation abolishes these effects and improves MGO-related impairment of wound healing. The current study was conducted to examine the effects of MGO on the injury and function in human skin keratinocytes and then to evaluate the protective action of a novel H2S-releasing molecule. An N-mercapto-based H2S donor (NSHD)-1 was synthesized and its ability to release H2S was observed in cell medium and cells, respectively. HaCaT cells, a cell line of human skin keratinocyte, were exposed to MGO to establish an in vitro diabetic wound healing model. NSHD-1 was added to the cells before MGO exposure and the improvement of cell function was observed in respect of cellular viability, apoptosis, oxidative stress, mitochondrial membrane potential (MMP) and behavioral function. Treatment with MGO decreased cell viability, induced cellular apoptosis, increased intracellular reactive oxygen species (ROS) content and depressed MMP in HaCaT cells. The treatment also damaged cell behavioral function, characterized by decreased cellular adhesion and migration. The synthesized H2S-releasing molecule, NSHD-1, was able to increase H2S levels in both cell medium and cells. Importantly, pretreatment with NSHD-1 inhibited MGO-induced decreases in cell viability and MMP, increases in apoptosis and ROS accumulation in HaCaT cells. The pretreatment was also able to improve adhesion and migration function. These results demonstrate that the novel synthesized H2S donor is able to protect human skin keratinocytes against MGO-induced injury and behavior dysfunction. We believe that more reasonable H2S-releasing molecules will bring relief to patients suffering from delayed wound healing in diabetes mellitus in the future.
登录
查看更多内容
影响因子:
7.7
作者:
Liu F;Chen DD;Sun X;Xie HH;Yuan H;Jia W;Chen AF
通讯作者:
Chen AF
DOI:
10.1016/s0006-291x(02)00576-4
发表时间:
2002-06-28
影响因子:
3.1
作者:
Bae, JS;Lee, SH;Kim, IS
通讯作者:
Kim, IS
DOI:
10.1016/j.bbrc.2004.06.011
发表时间:
2004-07-30
影响因子:
3.1
作者:
Fukunaga, M;Miyata, S;Kasuga, M
通讯作者:
Kasuga, M
影响因子:
4.3
作者:
Dong, Xiao-Bian;Yang, Chun-Tao;Liao, Xin-Xue
通讯作者:
Liao, Xin-Xue
影响因子:
9.8
作者:
Dhar, Arti;Desai, Kaushik;Wu, Lingyun
通讯作者:
Wu, Lingyun